All you need to know on what has changed in Health Canada’s latest update and how to plan ahead ~Health Canada has published Version 4.0 of the Good Manufacturing Practices (GMP) Guide for Natural ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that data ...

Real world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 83% overall survival at day 28, for patients infected with highly resistant metallo-beta lactamase ...

Neuland Laboratories, a global contract development and manufacturing organization (CDMO) specialising in complex APIs, has today announced a leadership change. Saharsh Davuluri will assume the role ...

AmpleLogic, a leading provider of AI-driven compliance and digital transformation solutions for the life sciences industry, today announced its advanced AI-powered Quality Management System (QMS) ...

Global 3D Printing Medical Devices Market OverviewThe global 3D printing medical devices market is poised for strong expansion, projected to grow at a CAGR of nearly 17% during the forecast period.

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced that it will report its first quarter 2026 financial results after ...

Report OverviewThe global contract research organization (CRO) services market is poised for steady expansion, projected to grow at a CAGR of around 9% over the next five years. This growth trajectory ...

In the rapidly evolving world of senior living and long-term care (LTC), artificial intelligence (AI) is emerging as a game-changer. From enhancing resident wellness to optimizing operational ...

POTOMAC, MD / ACCESS Newswire / April 7, 2026 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company"), a clinical-stage biotechnology company developing innovative treatments for Alzheimer's ...

Collaboration leverages Alloy’s platform to accelerate the development of innovative oligonucleotide therapeutics- Latest collaboration between the two companies builds on past work together, ...

Differentiated Oral Candidate Targeting Soluble Amyloid Oligomer Pathology, with Additional Mechanism of Action as APOE4 CorrectorALZ-507 IND Program Demonstrated Favorable Nonclinical Safety and ...